An exploratory study of venetoclax in combination with bortezomib-cyclophosphamide-dexamethasone (VCD) induction therapy in newly diagnosed transplant eligible (NDTE MM) multiple myeloma with proteomic correlative studies.

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)
  • Mollee, Peter (Chief Investigator (CI))
  • Harrison, Simon James (Chief Investigator (CI))
  • Quach, Hang, (Chief Investigator (CI))
  • Ho, Joy (Chief Investigator (CI))

Project: Research

StatusActive
Effective start/end date27/09/1827/09/23